2022-08-20 高雄萬豪酒店 10F皇喜會議室 10D-2
| 時間 | 主題 | 講者 | 座長 | 摘要 | 簡報 |
|---|---|---|---|---|---|
15:30 ~ 15:50 |
瀏覽海報時間 |
All |
黃書彬, 楊晨洸 |
||
15:50 ~ 15:54 |
MP05-01: Survival impact of nephroureterectomy for de novo stage IV (nonmetastatic and metastatic) upper tract urothelial carcinoma |
林威宇 |
黃書彬, 楊晨洸 |
||
15:54 ~ 15:58 |
MP05-02: Melatonin suppresses tumor malignancy through the NF-KB/P65/HIF-1a pathway in urothelial carcinoma |
陳龍 |
黃書彬, 楊晨洸 |
||
15:58 ~ 16:02 |
MP05-03: Influence of novel inflammatory biomarkers on prediction for patients with upper tract urothelial carcinoma |
李一宏 |
黃書彬, 楊晨洸 |
||
16:02 ~ 16:06 |
MP05-04: Effect of Metformin on overall survival of upper tract urothelial carcinoma in patients with type 2 diabetes |
吳冠賢 |
黃書彬, 楊晨洸 |
||
16:06 ~ 16:10 |
MP05-05: Clinical outcomes of plasmacytoid urothelial carcinoma of urinary bladder: A single institution experience |
吳英龍 |
黃書彬, 楊晨洸 |
||
16:10 ~ 16:14 |
MP05-06: Validation of neutrophil to lymphocyte ratio for prognosis and treatment selection in muscle invasive bladder cancer: A single-institutional longitudinal study |
蔡勝閔 |
黃書彬, 楊晨洸 |
||
16:14 ~ 16:18 |
MP05-07: Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway |
施孟宏 |
黃書彬, 楊晨洸 |
||
16:22 ~ 16:26 |
MP05-09: Suppression of tumor characteristics of urothelial carcinoma cells by berberrubine and resveratrol by GSTM2 induction |
周主民 |
黃書彬, 楊晨洸 |
||
16:26 ~ 16:30 |
MP05-10: Thrombospondin-4 induces lymphangiogenesis by lymphatic endothelial cell recruitment in bladder tumor |
仇光宇 |
黃書彬, 楊晨洸 |